These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 18987546)
21. Characterization of CD24 expression in intraductal papillary mucinous neoplasms and ductal carcinoma of the pancreas. Ikenaga N; Ohuchida K; Mizumoto K; Yu J; Kayashima T; Hayashi A; Nakata K; Tanaka M Hum Pathol; 2010 Oct; 41(10):1466-74. PubMed ID: 20619441 [TBL] [Abstract][Full Text] [Related]
22. Anaplastic oligodendroglioma in an adolescent with Lynch syndrome. Heath JA; Ng J; Beshay V; Coleman L; Lo P; Amor DJ Pediatr Blood Cancer; 2013 Jun; 60(6):E13-5. PubMed ID: 23255519 [TBL] [Abstract][Full Text] [Related]
23. Pancreatic medullary carcinoma developed on a pancreatic intraductal papillary mucinous neoplasm with loss of MSH2 and MSH6 expression: a case report. Verocq C; Racu ML; Bafort D; Butorano G; Perez-Casanova Garcia L; Navez J; Witterwulghe M; Sheahan K; Swan N; Closset J; Van Laethem JL; Maris C; D'Haene N Diagn Pathol; 2021 Dec; 16(1):117. PubMed ID: 34895278 [TBL] [Abstract][Full Text] [Related]
24. Copy number gain of chromosome 3q is a recurrent event in patients with intraductal papillary mucinous neoplasm (IPMN) associated with disease progression. Durante S; Vecchiarelli S; Astolfi A; Grassi E; Casadei R; Santini D; Panzacchi R; Ricci C; Serravalle S; Tarantino G; Falconi M; Teti G; Indio V; Pession A; Minni F; Biasco G; Di Marco M Oncotarget; 2016 Nov; 7(46):74797-74806. PubMed ID: 27566563 [TBL] [Abstract][Full Text] [Related]
25. Detection of Hot-Spot Mutations in Circulating Cell-Free DNA From Patients With Intraductal Papillary Mucinous Neoplasms of the Pancreas. Berger AW; Schwerdel D; Costa IG; Hackert T; Strobel O; Lam S; Barth TF; Schröppel B; Meining A; Büchler MW; Zenke M; Hermann PC; Seufferlein T; Kleger A Gastroenterology; 2016 Aug; 151(2):267-70. PubMed ID: 27343369 [TBL] [Abstract][Full Text] [Related]
26. A novel complex mutation in MSH2 contributes to both Muir-Torre and Lynch Syndrome. Perera S; Ramyar L; Mitri A; Pollett A; Gallinger S; Speevak MD; Aronson M; Bapat B J Hum Genet; 2010 Jan; 55(1):37-41. PubMed ID: 19911012 [TBL] [Abstract][Full Text] [Related]
27. Pancreatic ductal adenocarcinoma derived from IPMN and pancreatic ductal adenocarcinoma concomitant with IPMN. Yamaguchi K; Kanemitsu S; Hatori T; Maguchi H; Shimizu Y; Tada M; Nakagohri T; Hanada K; Osanai M; Noda Y; Nakaizumi A; Furukawa T; Ban S; Nobukawa B; Kato Y; Tanaka M Pancreas; 2011 May; 40(4):571-80. PubMed ID: 21499212 [TBL] [Abstract][Full Text] [Related]
28. Familial Intraductal Papillary Mucinous Neoplasm Associated With the Germline MSH6 Missense Variant and Progression of Pancreatic cancer. Tezuka K; Yamakawa M; Murakami R; Hirai I; Toya R; Suzuki A; Kawamura H; Miyano Y; Sato H; Motoi F Pancreas; 2024 Jul; 53(6):e476-e486. PubMed ID: 38416847 [TBL] [Abstract][Full Text] [Related]
29. Aberrant expression of cdx2 homeobox gene in intraductal papillary-mucinous neoplasm of the pancreas but not in pancreatic ductal adenocarcinoma. Yeh TS; Ho YP; Chiu CT; Chen TC; Jan YY; Chen MF Pancreas; 2005 Apr; 30(3):233-8. PubMed ID: 15782100 [TBL] [Abstract][Full Text] [Related]
30. Increased K-ras mutation and expression of S100A4 and MUC2 protein in the malignant intraductal papillary mucinous tumor of the pancreas. Jang JY; Park YC; Song YS; Lee SE; Hwang DW; Lim CS; Lee HE; Kim WH; Kim SW J Hepatobiliary Pancreat Surg; 2009; 16(5):668-74. PubMed ID: 19412570 [TBL] [Abstract][Full Text] [Related]
32. Benign intraductal papillary-mucinous neoplasm of the pancreas associated with spontaneous pancreaticogastric and pancreaticoduodenal fistulas. Jausset F; Delvaux M; Dumitriu D; Bressenot A; Bruot O; Mathias J; Regent D; Laurent V Digestion; 2010; 82(1):42-6. PubMed ID: 20203511 [TBL] [Abstract][Full Text] [Related]
33. A comparison between intraductal papillary neoplasms of the biliary tract (BT-IPMNs) and intraductal papillary mucinous neoplasms of the pancreas (P-IPMNs) reveals distinct clinical manifestations and outcomes. Minagawa N; Sato N; Mori Y; Tamura T; Higure A; Yamaguchi K Eur J Surg Oncol; 2013 Jun; 39(6):554-8. PubMed ID: 23506840 [TBL] [Abstract][Full Text] [Related]
34. [Intraductal papillary mucinous neoplasm of the pancreas: case report and review of the literature]. Iveković H; Rustemović N; Opacić M; Deban O; Romic B; Razumović JJ; Ostojić R; Pulanić R; Vucelić B Lijec Vjesn; 2012; 134(1-2):25-8. PubMed ID: 22519250 [TBL] [Abstract][Full Text] [Related]
35. Clinicopathologic study of the MIB-1 labeling index (Ki67) and postoperative prognosis for intraductal papillary mucinous neoplasms and ordinary ductal adenocarcinoma. Takeshita A; Kimura W; Hirai I; Takasu N; Moriya T; Tezuka K; Watanabe T Pancreas; 2012 Jan; 41(1):114-20. PubMed ID: 22143341 [TBL] [Abstract][Full Text] [Related]
36. Papillary thyroid carcinoma (PTC) in Lynch syndrome: Report of two cases and discussion on Lynch syndrome behaviour and genetics. Pelizzo MR; Pennelli G; Zane M; Galuppini F; Colletti PM; Merante Boschin I; Rubello D Biomed Pharmacother; 2015 Aug; 74():9-16. PubMed ID: 26349957 [TBL] [Abstract][Full Text] [Related]